世界の気管支炎治療市場は、予測期間中に約4.76 %のCAGRで推移し、2022年から2026年の間に11億2,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。喫煙率の上昇、気管支炎の発生率が上昇する老年人口の増加、呼吸中の有害化学物質や汚染物質のレベルの上昇などが市場を牽引しています。さらに、喫煙率の増加は市場の成長を後押しすることも予想されます。
本調査では、今後数年間の気管支炎治療市場の成長を牽引する主な要因の一つとして、世界的な医療費の増加を挙げています。また、市販の気管支炎治療薬の売上増加や、新しい気管支炎治療薬の開発は、市場の大きな需要につながると考えられます。
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な気管支炎治療市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Drug Class
5.1 Market segments
Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
5.2 Comparison by Drug Class
Exhibit 26: Chart on Comparison by Drug Class
Exhibit 27: Data Table on Comparison by Drug Class
5.3 Antibiotics - Market size and forecast 2021-2026
Exhibit 28: Chart on Antibiotics - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Antibiotics - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Antibiotics - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Antibiotics - Year-over-year growth 2021-2026 (%)
5.4 Anti inflammatory Drugs - Market size and forecast 2021-2026
Exhibit 32: Chart on Anti inflammatory Drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Anti inflammatory Drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Anti inflammatory Drugs - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Anti inflammatory Drugs - Year-over-year growth 2021-2026 (%)
5.5 Bronchodilator - Market size and forecast 2021-2026
Exhibit 36: Chart on Bronchodilator - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Bronchodilator - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Bronchodilator - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Bronchodilator - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Drug Class
Exhibit 40: Market opportunity by Drug Class ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 Australia - Market size and forecast 2021-2026
Exhibit 74: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Australia - Year-over-year growth 2021-2026 (%)
7.11 New Zealand - Market size and forecast 2021-2026
Exhibit 78: Chart on New Zealand - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on New Zealand - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on New Zealand - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on New Zealand - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AstraZeneca Plc
Exhibit 89: AstraZeneca Plc - Overview
Exhibit 90: AstraZeneca Plc - Product / Service
Exhibit 91: AstraZeneca Plc - Key news
Exhibit 92: AstraZeneca Plc - Key offerings
10.4 Bayer AG
Exhibit 93: Bayer AG - Overview
Exhibit 94: Bayer AG - Business segments
Exhibit 95: Bayer AG - Key news
Exhibit 96: Bayer AG - Key offerings
Exhibit 97: Bayer AG - Segment focus
10.5 Boehringer Ingelheim International GmbH
Exhibit 98: Boehringer Ingelheim International GmbH - Overview
Exhibit 99: Boehringer Ingelheim International GmbH - Business segments
Exhibit 100: Boehringer Ingelheim International GmbH - Key news
Exhibit 101: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 102: Boehringer Ingelheim International GmbH - Segment focus
10.6 Cipla Ltd.
Exhibit 103: Cipla Ltd. - Overview
Exhibit 104: Cipla Ltd. - Business segments
Exhibit 105: Cipla Ltd. - Key news
Exhibit 106: Cipla Ltd. - Key offerings
Exhibit 107: Cipla Ltd. - Segment focus
10.7 Dr. Reddys Laboratories Ltd.
Exhibit 108: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 109: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 110: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 111: Dr. Reddys Laboratories Ltd. - Segment focus
10.8 GlaxoSmithKline Plc
Exhibit 112: GlaxoSmithKline Plc - Overview
Exhibit 113: GlaxoSmithKline Plc - Business segments
Exhibit 114: GlaxoSmithKline Plc - Key news
Exhibit 115: GlaxoSmithKline Plc - Key offerings
Exhibit 116: GlaxoSmithKline Plc - Segment focus
10.9 Lupin Ltd.
Exhibit 117: Lupin Ltd. - Overview
Exhibit 118: Lupin Ltd. - Product / Service
Exhibit 119: Lupin Ltd. - Key news
Exhibit 120: Lupin Ltd. - Key offerings
10.10 Merck and Co. Inc.
Exhibit 121: Merck and Co. Inc. - Overview
Exhibit 122: Merck and Co. Inc. - Business segments
Exhibit 123: Merck and Co. Inc. - Key news
Exhibit 124: Merck and Co. Inc. - Key offerings
Exhibit 125: Merck and Co. Inc. - Segment focus
10.11 Pfizer Inc.
Exhibit 126: Pfizer Inc. - Overview
Exhibit 127: Pfizer Inc. - Product / Service
Exhibit 128: Pfizer Inc. - Key news
Exhibit 129: Pfizer Inc. - Key offerings
10.12 Sanofi SA
Exhibit 130: Sanofi SA - Overview
Exhibit 131: Sanofi SA - Business segments
Exhibit 132: Sanofi SA - Key news
Exhibit 133: Sanofi SA - Key offerings
Exhibit 134: Sanofi SA - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on Antibiotics - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Antibiotics - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Antibiotics - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Antibiotics - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Anti inflammatory Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Anti inflammatory Drugs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Anti inflammatory Drugs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Anti inflammatory Drugs - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Bronchodilator - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Bronchodilator - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Bronchodilator - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Bronchodilator - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Drug Class ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Australia - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on New Zealand - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on New Zealand - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on New Zealand - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on New Zealand - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AstraZeneca Plc - Overview
Exhibits90: AstraZeneca Plc - Product / Service
Exhibits91: AstraZeneca Plc - Key news
Exhibits92: AstraZeneca Plc - Key offerings
Exhibits93: Bayer AG - Overview
Exhibits94: Bayer AG - Business segments
Exhibits95: Bayer AG - Key news
Exhibits96: Bayer AG - Key offerings
Exhibits97: Bayer AG - Segment focus
Exhibits98: Boehringer Ingelheim International GmbH - Overview
Exhibits99: Boehringer Ingelheim International GmbH - Business segments
Exhibits100: Boehringer Ingelheim International GmbH - Key news
Exhibits101: Boehringer Ingelheim International GmbH - Key offerings
Exhibits102: Boehringer Ingelheim International GmbH - Segment focus
Exhibits103: Cipla Ltd. - Overview
Exhibits104: Cipla Ltd. - Business segments
Exhibits105: Cipla Ltd. - Key news
Exhibits106: Cipla Ltd. - Key offerings
Exhibits107: Cipla Ltd. - Segment focus
Exhibits108: Dr. Reddys Laboratories Ltd. - Overview
Exhibits109: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits110: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits111: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits112: GlaxoSmithKline Plc - Overview
Exhibits113: GlaxoSmithKline Plc - Business segments
Exhibits114: GlaxoSmithKline Plc - Key news
Exhibits115: GlaxoSmithKline Plc - Key offerings
Exhibits116: GlaxoSmithKline Plc - Segment focus
Exhibits117: Lupin Ltd. - Overview
Exhibits118: Lupin Ltd. - Product / Service
Exhibits119: Lupin Ltd. - Key news
Exhibits120: Lupin Ltd. - Key offerings
Exhibits121: Merck and Co. Inc. - Overview
Exhibits122: Merck and Co. Inc. - Business segments
Exhibits123: Merck and Co. Inc. - Key news
Exhibits124: Merck and Co. Inc. - Key offerings
Exhibits125: Merck and Co. Inc. - Segment focus
Exhibits126: Pfizer Inc. - Overview
Exhibits127: Pfizer Inc. - Product / Service
Exhibits128: Pfizer Inc. - Key news
Exhibits129: Pfizer Inc. - Key offerings
Exhibits130: Sanofi SA - Overview
Exhibits131: Sanofi SA - Business segments
Exhibits132: Sanofi SA - Key news
Exhibits133: Sanofi SA - Key offerings
Exhibits134: Sanofi SA - Segment focus
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations
